EE+ POEM Archive
Zoledronate 5 mg every 18 months reduces fragility fractures in women over 65 with osteopenia (NNT = 15 over 6 years)
Zoledronate 5 mg every 18 months reduces fragility fractures in women over 65 with osteopenia (NNT = 15 over 6 years) is a topic covered in the EE+ POEM Archive.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Barry, Henry, et al., editors. "Zoledronate 5 Mg Every 18 Months Reduces Fragility Fractures in Women Over 65 With Osteopenia (NNT = 15 Over 6 Years)." EE+ POEM Archive, John Wiley & Sons, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314709/all/Zoledronate_5_mg_every_18_months_reduces_fragility_fractures_in_women_over_65_with_osteopenia__NNT_=_15_over_6_years_.
Zoledronate 5 mg every 18 months reduces fragility fractures in women over 65 with osteopenia (NNT = 15 over 6 years). In: Barry HH, Ebell MHM, Shaughnessy AFA, et al, eds. EE+ POEM Archive. John Wiley & Sons; 2019. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314709/all/Zoledronate_5_mg_every_18_months_reduces_fragility_fractures_in_women_over_65_with_osteopenia__NNT_=_15_over_6_years_. Accessed March 30, 2023.
Zoledronate 5 mg every 18 months reduces fragility fractures in women over 65 with osteopenia (NNT = 15 over 6 years). (2019). In Barry, H., Ebell, M. H., Shaughnessy, A. F., & Slawson, D. C. (Eds.), EE+ POEM Archive. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314709/all/Zoledronate_5_mg_every_18_months_reduces_fragility_fractures_in_women_over_65_with_osteopenia__NNT_=_15_over_6_years_
Zoledronate 5 Mg Every 18 Months Reduces Fragility Fractures in Women Over 65 With Osteopenia (NNT = 15 Over 6 Years) [Internet]. In: Barry HH, Ebell MHM, Shaughnessy AFA, Slawson DCD, editors. EE+ POEM Archive. John Wiley & Sons; 2019. [cited 2023 March 30]. Available from: https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314709/all/Zoledronate_5_mg_every_18_months_reduces_fragility_fractures_in_women_over_65_with_osteopenia__NNT_=_15_over_6_years_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Zoledronate 5 mg every 18 months reduces fragility fractures in women over 65 with osteopenia (NNT = 15 over 6 years)
ID - 1314709
ED - Barry,Henry,
ED - Ebell,Mark H,
ED - Shaughnessy,Allen F,
ED - Slawson,David C,
BT - EE+ POEM Archive
UR - https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314709/all/Zoledronate_5_mg_every_18_months_reduces_fragility_fractures_in_women_over_65_with_osteopenia__NNT_=_15_over_6_years_
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
